HR23B, a biomarker for HDAC inhibitors

HR23B, a biomarker for HDAC inhibitors

<p>As our understanding of cancer biology increases and novel therapies are developed, an increasing number of predictive biomarkers are becoming clinically available. Aberrant acetylation has been strongly linked to tumourigenesis and the modulation of acetylation through targeting histone d...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Khan, OA
Rannpháirtithe:	La Thangue, NB
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	2013
Ábhair:	Pharmacology Tumours Clinical laboratory sciences Medical Sciences Oncology

Míreanna comhchosúla

Mitochondrial modulators of hypoxia-related pathways in tumours
de réir: Snell, CE
Foilsithe / Cruthaithe: (2013)

Role of HR23B, HDAC6 and Myd88 and their interplay in response to HDAC inhibitor treatment
de réir: New, M
Foilsithe / Cruthaithe: (2014)

Angiogenesis in human lung tumours
de réir: Ferguson, ML
Foilsithe / Cruthaithe: (2008)

Risk factors for haemorrhage in patients with haematological malignancies
de réir: Estcourt, LJ
Foilsithe / Cruthaithe: (2014)

Regulation of stemness and differentiation in colorectal cancer
de réir: Gandhi, S
Foilsithe / Cruthaithe: (2010)

Development of sindbis virus as an oncolytic agent
de réir: Kueberuwa, GLB
Foilsithe / Cruthaithe: (2012)

Tumour-stroma interaction in pancreatic cancer
de réir: Lunardi, S
Foilsithe / Cruthaithe: (2013)

Targeting EGFR signalling pathway in triple negative breast cancer
de réir: Albukhari, A
Foilsithe / Cruthaithe: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
de réir: Albukhari, A
Foilsithe / Cruthaithe: (2014)

Characterising the role of circulating immune cells in brain metastasis
de réir: Balathasan, L
Foilsithe / Cruthaithe: (2012)

The role of ATF4 in hypoxia-induced cell death in cancer
de réir: Pike, L, et al.
Foilsithe / Cruthaithe: (2011)

Combining regulatory angiogenic gene therapy and virotherapy for the treatment of breast cancer
de réir: Bazan Peregrino, M
Foilsithe / Cruthaithe: (2007)

Modulating the immune system by amino acid depletion - IDO and beyond
de réir: Vallius, L
Foilsithe / Cruthaithe: (2011)

Novel signalling pathways regulating epithelial-mesenchymal transition in bone metastatic prostate cancer
de réir: Rao, SR
Foilsithe / Cruthaithe: (2014)

Arginine methylation in the E2F1 pathway
de réir: Zheng, S
Foilsithe / Cruthaithe: (2013)

Investigating a role of ASPP2 in the cellular response to infection
de réir: Lim, Y, et al.
Foilsithe / Cruthaithe: (2014)

Development of models and methods to assess the efficacy of anti-cancer drugs targeted to the mitochondria
de réir: Potter, M
Foilsithe / Cruthaithe: (2014)

Improving intraperitoneal adenovirus virotherapy for ovarian cancer
de réir: Thoma, CMM
Foilsithe / Cruthaithe: (2011)

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy.
de réir: Khan, O, et al.
Foilsithe / Cruthaithe: (2010)

The role of host microenvironment in the pathogenesis of multiple myeloma
de réir: Lwin, STS
Foilsithe / Cruthaithe: (2014)

Targeting polymer coated adenovirus to tumour-associated vasculature
de réir: Bachtarzi, H
Foilsithe / Cruthaithe: (2010)

Managing melanoma in the era of personalised therapy: more than one disease
de réir: Rughani, M, et al.
Foilsithe / Cruthaithe: (2012)

Loss of chaperone protein in human cancer
de réir: Adighibe, O
Foilsithe / Cruthaithe: (2012)

Tissue expression and functional insights into HIF prolyl hydroxylase domain enzymes
de réir: Wijeyekoon, JB
Foilsithe / Cruthaithe: (2013)

Tolerance in renal transplantation: is mixed chimerism the missing link?
de réir: Janes, S, et al.
Foilsithe / Cruthaithe: (2009)

The role of DLL4-NOTCH signalling in endothelial cell metabolism
de réir: Harjes, U
Foilsithe / Cruthaithe: (2014)

The identification and validation of Auger electron-emitting radiopharmaceuticals targeting telomerase for cancer therapy
de réir: Jackson, M
Foilsithe / Cruthaithe: (2013)

The role of HER4 in relation to trastuzumab resistance and prognosis in HER2 positive breast cancer
de réir: Mohd Nafi, SN
Foilsithe / Cruthaithe: (2014)

Development of clinical biomarkers of DNA double strand breaks for cancer care
de réir: Shah, K
Foilsithe / Cruthaithe: (2012)

Biomarkers of anti-angiogenic therapy in breast cancer
de réir: Mehta, S
Foilsithe / Cruthaithe: (2014)

Development of bioreductive inhibitors of checkpoint kinase 1 to target hypoxic tumours
de réir: Körner, C
Foilsithe / Cruthaithe: (2015)

Selective targeting of homologous recombination deficiency
de réir: Zimmer, J
Foilsithe / Cruthaithe: (2014)

The three methyls: the function and therapeutic potential of histone H3K36 trimethylation
de réir: Pfister, SX
Foilsithe / Cruthaithe: (2014)

Impact of TMPRSS2-ERG fusion gene on prostate cancer cell response to chemotherapy, radiotherapy and androgen deprivation therapy
de réir: Ovtcharov, S
Foilsithe / Cruthaithe: (2015)

Targeting cell adhesion as a method of sensitising metastatic tumour cells to TRAIL-induced apoptosis
de réir: Phipps, L
Foilsithe / Cruthaithe: (2011)

Cortical dynamics subserving visual apparent motion
de réir: Ahmed, B, et al.
Foilsithe / Cruthaithe: (2008)

Investigating the endogenous role of human n-acetyltransferase 1, as potential breast cancer biomarker, using chemical biology
de réir: Laurieri, N
Foilsithe / Cruthaithe: (2012)

Heterogeneity of tumour response to hypoxia: carbonic anhydrase IX induction defines a subpopulation of hypoxic cells with stem cell properties and drug resistance
de réir: Ledaki, I
Foilsithe / Cruthaithe: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors.
de réir: New, M, et al.
Foilsithe / Cruthaithe: (2013)

A regulatory circuit that involves HR23B and HDAC6 governs the biological response to HDAC inhibitors
de réir: New, M, et al.
Foilsithe / Cruthaithe: (2013)